Scientists test softer chemo to fight breast cancer with fewer side effects
NCT ID NCT07421141
Summary
This study is testing a new, potentially gentler combination of chemotherapy drugs given before surgery for early-stage HER2-positive breast cancer. It aims to see if this less toxic treatment works as well as the current standard by measuring if it completely removes the cancer. The trial involves 186 patients and compares the new drug combo to the standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
P.A. Hertsen Moscow Oncology Research Institute
Moscow, 125284, Russia
Conditions
Explore the condition pages connected to this study.